Home › NDC Lookup › RxCUI directory › RxCUI 141935

Haloperidol 2 MG/ML Oral Solution — RxCUI 141935

RxNorm drug concept · Semantic clinical drug
RxCUI 141935 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI141935
Official nameHaloperidol 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashaloperidol 2 MG per 1 ML Concentrate for Oral Solution; haloperidol 2 MG in 1 mL Concentrate for Oral Solution
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)7,744 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Haloperidol Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The monthly injection — haloperidol decanoate — is a long-acting form designed for people with schizophrenia who are already stable on oral haloperidol. The idea is to give you ste...
  • Why am I getting a monthly injection instead of just taking a pill every day?
  • The most common side effects involve movement — things like muscle stiffness, slow movement, tremor, or a restless urge to keep moving. These are worth mentioning to your doctor, b...
  • What side effects should I expect, and which ones mean I need to call someone right away?
📖 Read our full Haloperidol Injection guide →

🕸️ Concept Web — How Haloperidol 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Haloperidol 2 MG/ML Oral Solution RxCUI 141935

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Haloperidol 5093
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Haloperidol Oral Solution 372376
    • Haloperidol Oral Liquid Product 1160299
    • Haloperidol Oral Product 1160300
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Haloperidol 2 MG/ML 316028

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Haloperidol 2 MG/ML SCDC · 316028
  • Haloperidol Oral Solution SCDF · 372376
  • Haloperidol Oral Liquid Product SCDG · 1160299
  • Haloperidol Oral Product SCDG · 1160300

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 141935 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0581-04 120 mL in 1 BOTTLE (0121-0581-04) Haloperidol PAI Holdings, LLC dba PAI Pharma 2009-11-10
00121-0581-05 10 TRAY in 1 CASE (0121-0581-05) / 10 CUP, UNIT-DOSE in 1 T... Haloperidol PAI Holdings, LLC dba PAI Pharma 2009-11-10
00121-0581-15 15 mL in 1 BOTTLE (0121-0581-15) Haloperidol PAI Holdings, LLC dba PAI Pharma 2020-06-12
54838-0501-15 15 mL in 1 BOTTLE, DROPPER (54838-501-15) Haloperidol Lannett Company, Inc. 1993-09-28
54838-0501-40 120 mL in 1 BOTTLE, DROPPER (54838-501-40) Haloperidol Lannett Company, Inc. 1993-09-28
60687-0799-17 10 TRAY in 1 CASE (60687-799-17) / 10 CUP, UNIT-DOSE in 1 T... Haloperidol American Health Packaging 2024-04-15
72888-0173-47 15 mL in 1 BOTTLE (72888-173-47) Haloperidol Advagen Pharma Ltd 2024-01-31
72888-0173-48 120 mL in 1 BOTTLE (72888-173-48) Haloperidol Advagen Pharma Ltd 2024-01-31
Observed labelers: PAI Holdings, LLC dba PAI Pharma (3) · Advagen Pharma Ltd (2) · Lannett Company, Inc. (2) · American Health Packaging (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.